Effects of Interactive Toys and Robots on Anxiety and Fear in Children Receiving Nebulized Inhalation in the Pediatric Emergency Department
Launched by AYLIN KURT · Jun 29, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether playing with interactive toys and robots can help reduce anxiety and fear in children who are receiving nebulized inhalation treatment—a common breathing therapy—in a pediatric emergency room. The emergency room can be a scary place for children because of the unfamiliar environment, discomfort, and being away from their parents. The study aims to see if these fun, engaging tools can make the experience less stressful and help children feel calmer during their treatment.
Children between the ages of 4 and 10 who need this breathing treatment in the emergency department may be eligible to join, as long as their parents agree and the child can communicate without difficulties like speech or vision problems. If selected, children will be randomly assigned to either play with interactive toys and robots during their treatment or to receive usual care without these tools. This study will help doctors understand if these playful distractions really make a difference in easing children’s fears and improving their overall experience during medical care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being a child between the ages of 4-10,
- • Receiving nebulized inhalation treatment in the pediatric emergency department,
- • The parent agreeing to participate in the research,
- • The child not having speech or vision impairments or any other disabilities that would hinder or prevent communication.
- Exclusion Criteria:
- • Children whose parents' permission cannot be obtained
- • The child's speech and vision impairment, or any other disability that would make communication difficult or prevent it.
About Aylin Kurt
Aylin Kurt is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on ethical practices and patient safety, Aylin Kurt oversees the design, implementation, and management of clinical trials across various therapeutic areas. The organization emphasizes collaboration with healthcare professionals and regulatory bodies to ensure compliance and transparency throughout the research process. Aylin Kurt is dedicated to delivering reliable data that supports the development of new treatments, ultimately aiming to improve patient outcomes and contribute to the advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported